Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223

被引：0
|
作者：
Maarten J. van der Doelen
Agnes Stockhaus
Yuanjun Ma
Niven Mehra
Jeffrey Yachnin
Winald R. Gerritsen
Sten Nilsson
Inge M. van Oort
Anders Ullén
机构：
[1] Radboud University Medical Center,Department of Urology
[2] Radboud University Medical Center,Department of Medical Oncology
[3] Mälarsjukhuset,Department of Oncology
[4] Karolinska Institutet,Pathology
[5] Karolinska University Hospital,Department of Oncology
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2021年 / 48卷
关键词：
Alkaline phosphatase; Biomarker; Bone metastases; Castration-resistant prostate cancer; Radium-223; Prognostic variables;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3325 / 3334
页数：9
相关论文
共 50 条
  • [31] Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program
    Saad, Fred
    Gillessen, Silke
    Heinrich, Daniel
    Keizman, Daniel
    O'Sullivan, Joe M.
    Nilsson, Sten
    Miller, Kurt
    Wirth, Manfred
    Reeves, John
    Seger, Monica
    Carles, Joan
    Heidenreich, Axel
    CLINICAL GENITOURINARY CANCER, 2019, 17 (05) : 348 - +
  • [32] Radium-223: Insight and Perspectives in Bone-metastatic Castration-resistant Prostate Cancer
    Buroni, Federica Eleonora
    Persico, Marco Giovanni
    Pasi, Francesca
    Lodola, Lorenzo
    Nano, Rosanna
    Aprile, Carlo
    ANTICANCER RESEARCH, 2016, 36 (11) : 5719 - 5730
  • [33] Complete Cycles of Radium-223 Improve Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer: A Retrospective Study
    Yang, Han-chung
    Chang, Li-wen
    Li, Jian-ri
    Wang, Shian-shiang
    Yang, Cheng-kuang
    Chen, Chuan-shu
    Lu, Kevin
    Chen, Cheng-che
    Wang, Shu-chi
    Lin, Chia-yen
    Cheng, Chen-li
    Ou, Yen-chuan
    Chiu, Kun-yuan
    Hung, Sheng-chun
    ANTICANCER RESEARCH, 2023, 43 (04) : 1809 - 1816
  • [34] Radium-223 dichloride: illustrating the benefits of a multidisciplinary approach for patients with metastatic castration-resistant prostate cancer
    Renzulli, Joseph F., II
    Collins, Jennifer
    Mega, Anthony
    JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2015, 8 : 279 - 286
  • [35] Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer
    Matsubara, Nobuaki
    Nagamori, Satsohi
    Wakumoto, Yoshiaki
    Uemura, Hirotsugu
    Kimura, Go
    Yokomizo, Akira
    Kikukawa, Hiroaki
    Mizokami, Atsushi
    Kosaka, Takeo
    Masumori, Naoya
    Kawasaki, Yoshihide
    Yonese, Junji
    Nasu, Yasutomo
    Fukasawa, Satoshi
    Sugiyama, Takayuki
    Kinuya, Seigo
    Hosono, Makoto
    Yamaguchi, Iku
    Tsutsui, Hirokazu
    Uemura, Hiroji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (01) : 173 - 180
  • [36] Prognostic Value of 18F-Choline PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radium-223
    Filippi, Luca
    Spinelli, Gian Paolo
    Chiaravalloti, Agostino
    Schillaci, Orazio
    Equitani, Francesco
    Bagni, Oreste
    BIOMEDICINES, 2020, 8 (12) : 1 - 12
  • [37] The role of radium-223 in the evolving treatment landscape of metastatic castration-resistant prostate cancer: A narrative review
    Pinto, Alvaro
    Dominguez, Mario
    Gomez-Iturriaga, Alfonso
    Rodriguez-Vida, Alejo
    Vallejo-Casas, Juan Antonio
    Castro, Elena
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 210
  • [38] Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program
    Axel Heidenreich
    Silke Gillessen
    Daniel Heinrich
    Daniel Keizman
    Joe M. O’Sullivan
    Joan Carles
    Manfred Wirth
    Kurt Miller
    John Reeves
    Monica Seger
    Sten Nilsson
    Fred Saad
    BMC Cancer, 19
  • [39] Radium-223 dichloride for the treatment of bone metastatic castration-resistant prostate cancer: an evaluation of its safety
    Nilsson, Sten
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (07) : 1127 - 1136
  • [40] Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program
    Heidenreich, Axel
    Gillessen, Silke
    Heinrich, Daniel
    Keizman, Daniel
    O'Sullivan, Joe M.
    Carles, Joan
    Wirth, Manfred
    Miller, Kurt
    Reeves, John
    Seger, Monica
    Nilsson, Sten
    Saad, Fred
    BMC CANCER, 2019, 19 (1)
12345